ATE334656T1 - Flüssige pharmazeutische zusammensetzung - Google Patents

Flüssige pharmazeutische zusammensetzung

Info

Publication number: ATE334656T1
Authority: AT; Austria
Prior art keywords: pharmaceutical composition; liquid pharmaceutical; liquid; composition; pharmaceutical
Prior art date: 2001-05-25

Application number

AT02727834T

Other languages

English (en)

Inventor

Neema Mahesh Kulkarni

Michael Schneider

Steven Bernard Silbering

Hans Richard Meyer-Wonnay

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-25

Filing date

2002-04-29

Publication date

2006-08-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26968180&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE334656(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-04-29 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

2006-08-15 Application granted granted Critical

2006-08-15 Publication of ATE334656T1 publication Critical patent/ATE334656T1/de

Links

239000007788 liquid Substances 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Physical Education & Sports Medicine (AREA)
Psychiatry (AREA)
Urology & Nephrology (AREA)
Orthopedic Medicine & Surgery (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Rheumatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Indole Compounds (AREA)
Pyrrole Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT02727834T 2001-05-25 2002-04-29 Flüssige pharmazeutische zusammensetzung ATE334656T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US29383201P	2001-05-25	2001-05-25
US34373301P	2001-10-25	2001-10-25

Publications (1)

Publication Number	Publication Date
ATE334656T1 true ATE334656T1 (de)	2006-08-15

Family

ID=26968180

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02727834T ATE334656T1 (de)	2001-05-25	2002-04-29	Flüssige pharmazeutische zusammensetzung

Country Status (43)

Country	Link
US (2)	US20020198261A1 (de)
EP (1)	EP1395242B1 (de)
JP (1)	JP2004534764A (de)
KR (1)	KR100582963B1 (de)
CN (1)	CN100346779C (de)
AP (1)	AP1815A (de)
AR (1)	AR033922A1 (de)
AT (1)	ATE334656T1 (de)
AU (1)	AU2002258026B2 (de)
BG (1)	BG108376A (de)
BR (1)	BR0209973A (de)
CA (1)	CA2446574C (de)
CR (1)	CR7150A (de)
CY (1)	CY1105147T1 (de)
CZ (1)	CZ299755B6 (de)
DE (1)	DE60213592T2 (de)
DK (1)	DK1395242T3 (de)
DO (1)	DOP2002000403A (de)
EA (1)	EA008087B1 (de)
EE (1)	EE200300587A (de)
EG (1)	EG24078A (de)
ES (1)	ES2265040T3 (de)
GE (1)	GEP20053620B (de)
HR (1)	HRP20030833B1 (de)
HU (1)	HUP0401366A2 (de)
IL (1)	IL158359A0 (de)
IS (1)	IS2428B (de)
MA (1)	MA27026A1 (de)
MX (1)	MXPA03009392A (de)
MY (1)	MY128615A (de)
NO (1)	NO20035200L (de)
NZ (1)	NZ529173A (de)
OA (1)	OA12604A (de)
PA (1)	PA8545901A1 (de)
PE (1)	PE20030087A1 (de)
PL (1)	PL366384A1 (de)
PT (1)	PT1395242E (de)
RS (1)	RS87203A (de)
SI (1)	SI1395242T1 (de)
SK (1)	SK286227B6 (de)
SV (1)	SV2003001053A (de)
WO (1)	WO2002094220A1 (de)
ZA (1)	ZA200308393B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL189872B1 (pl)	1996-07-24	2005-10-31	Warner Lambert Co	Zastosowanie izobutylogaby i jej pochodnych do wytwarzania leku do leczenia bólu
US8048917B2 (en)	2005-04-06	2011-11-01	Xenoport, Inc.	Prodrugs of GABA analogs, compositions and uses thereof
JP2005539092A (ja) *	2002-08-15	2005-12-22	ファイザー・インク	縮合二環式または三環式アミノ酸の治療における使用
NZ540591A (en) *	2002-12-13	2008-03-28	Warner Lambert Co	Pregabalin derivatives for the treatment of fibromyalgia and other disorders
CA2451267A1 (en) *	2002-12-13	2004-06-13	Warner-Lambert Company Llc	Pharmaceutical uses for alpha2delta ligands
AU2003301184A1 (en) *	2002-12-20	2004-07-22	Dynogen Pharmaceuticals Inc	METHODS OF TREATING NON-PAINFUL BLADDER DISORDERS USING Alpha2Delta SUBUNIT CALCIUM CHANNEL MODULATORS
US7169812B2 (en) *	2003-07-01	2007-01-30	Medtronic, Inc.	Process for producing injectable gabapentin compositions
AU2004271800A1 (en) *	2003-09-12	2005-03-24	Pfizer Inc.	Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors
CN1867359B (zh) *	2003-10-08	2010-12-15	马林克罗特公司	哌甲酯溶液及其制药用途和制备方法
US20050090549A1 (en) *	2003-10-23	2005-04-28	Medtronic, Inc.	Intrathecal gabapentin for treatment of pain
US20050090548A1 (en) *	2003-10-23	2005-04-28	Medtronic, Inc.	Intrathecal gabapentin for treatment of epilepsy
EP1543831A1 (de) *	2003-12-18	2005-06-22	Pfizer GmbH Arzneimittelwerk Gödecke	Zusammensetzung enthaltend Pregabalin
DE102004015752B4 (de) *	2004-03-31	2007-04-05	Christian-Albrechts-Universität Zu Kiel	Verwendung von Gabapentin-Laktam zur Behandlung renaler Erkrankungen
EP1806133A1 (de) *	2004-10-14	2007-07-11	Daikin Industries, Ltd.	Verfahren zur veränderung der umgebung und bei dem verfahren verwendete sprühflüssigkeit und sprühgerät
US20100168070A1 (en) *	2005-08-11	2010-07-01	Niklas Heine	Compounds for the treatment of alzheimer's disease
US20100144681A1 (en) *	2005-08-11	2010-06-10	Klaus Fuchs	Compounds for the treatment of alzheimer's disease
DE102007019071A1 (de) *	2007-04-23	2008-10-30	Ratiopharm Gmbh	Stabilisierte pharmazeutische Zusammensetzung enthaltend Pregabalin
SG157299A1 (en)	2008-05-09	2009-12-29	Agency Science Tech & Res	Diagnosis and treatment of kawasaki disease
EP2246044A1 (de) *	2009-04-21	2010-11-03	Pierre Fabre Dermo-Cosmétique	Kinderärztliche Lösungen für Betablocker
HU230031B1 (hu)	2010-03-01	2015-05-28	Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság	Pregabalint és izomaltot tartalmazó stabilizált gyógyszerkészítmény
TR201005241A1 (tr) *	2010-05-25	2012-01-23	Sanovel �La� San. Ve T�C. A.�.	Kontrollü salım sağlayan pregabalin solüsyon formülasyonu.
WO2015144825A1 (en) *	2014-03-27	2015-10-01	Sanovel Ilac Sanayi Ve Ticaret A.S.	Oral liquid pharmaceutical solution of gabapentin
CN104940930A (zh) *	2015-05-31	2015-09-30	黑龙江佰彤儿童药物研究有限公司	一种治疗儿童癫痫药物口服乳剂及其制备方法
WO2018167628A1 (en)	2017-03-13	2018-09-20	Ftf Pharma Private Limited	Pharmaceutical composition of oral suspension of immunosuppressive agents
WO2019038584A1 (en)	2017-08-19	2019-02-28	Ftf Pharma Private Limited	An oral pharmaceutical composition comprising zonisamide and process of preparation thereof
WO2019186515A1 (en) *	2018-03-30	2019-10-03	Ftf Pharma Private Limited	Liquid pharmaceutical compositions of antiepileptic drugs
WO2020039263A2 (en)	2018-08-18	2020-02-27	Ftf Pharma Private Limited	Pharmaceutical suspension for oral dosage
US11738020B2 (en)	2018-08-18	2023-08-29	Ftf Pharma Private Limited	Stable liquid vigabatrin pharmaceutical composition for oral dosage
WO2020039264A2 (en) *	2018-08-18	2020-02-27	Ftf Pharma Private Limited	Chemotherapeutic pharmaceutical suspension for oral dosage
DK3946260T3 (da)	2019-03-26	2026-03-23	Orion Corp	Pregabalinformuleringer og anvendelse deraf
HU231397B1 (hu)	2021-01-22	2023-06-28	Egis Gyógyszergyár Zrt.	Pregabalint tartalmazó topikális gyógyszerkészítmény
WO2022157525A1 (en)	2021-01-22	2022-07-28	Egis Gyógyszergyár Zrt.	Topical formulation containing modified phospholipid compounds
US20240099989A1 (en) *	2021-02-05	2024-03-28	Kinki University	Agent for preventing or improving peripheral neuropathy
US20250127739A1 (en) *	2021-08-31	2025-04-24	Avion Phamaceuticals, LLC	Stable gabapentin powder
WO2024058812A1 (en)	2022-09-16	2024-03-21	Pyros Pharmaceuticals, Inc.	Vigabatrin liquid pharmaceutical composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6294520B1 (en) *	1989-03-27	2001-09-25	Albert T. Naito	Material for passage through the blood-brain barrier
CA2327285C (en) *	1998-05-15	2005-06-14	Warner-Lambert Company	Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
CA2430298A1 (en) *	2000-11-30	2002-06-06	Banavara Lakshman Mylari	Combination of gaba agonists and sorbitol dehydrogenase inhibitors

2002
- 2002-04-29 DE DE60213592T patent/DE60213592T2/de not_active Expired - Fee Related
- 2002-04-29 OA OA1200300296A patent/OA12604A/en unknown
- 2002-04-29 CN CNB028098080A patent/CN100346779C/zh not_active Expired - Fee Related
- 2002-04-29 PL PL02366384A patent/PL366384A1/xx not_active Application Discontinuation
- 2002-04-29 KR KR1020037015326A patent/KR100582963B1/ko not_active Expired - Fee Related
- 2002-04-29 SI SI200230371T patent/SI1395242T1/xx unknown
- 2002-04-29 HR HR20030833A patent/HRP20030833B1/xx not_active IP Right Cessation
- 2002-04-29 AU AU2002258026A patent/AU2002258026B2/en not_active Ceased
- 2002-04-29 AP APAP/P/2003/002907A patent/AP1815A/en active
- 2002-04-29 MX MXPA03009392A patent/MXPA03009392A/es active IP Right Grant
- 2002-04-29 PT PT02727834T patent/PT1395242E/pt unknown
- 2002-04-29 RS YU87203A patent/RS87203A/sr unknown
- 2002-04-29 HU HU0401366A patent/HUP0401366A2/hu unknown
- 2002-04-29 NZ NZ529173A patent/NZ529173A/en unknown
- 2002-04-29 ES ES02727834T patent/ES2265040T3/es not_active Expired - Lifetime
- 2002-04-29 EA EA200301152A patent/EA008087B1/ru not_active IP Right Cessation
- 2002-04-29 EP EP02727834A patent/EP1395242B1/de not_active Expired - Lifetime
- 2002-04-29 SK SK1411-2003A patent/SK286227B6/sk not_active IP Right Cessation
- 2002-04-29 BR BR0209973-0A patent/BR0209973A/pt not_active IP Right Cessation
- 2002-04-29 DK DK02727834T patent/DK1395242T3/da active
- 2002-04-29 AT AT02727834T patent/ATE334656T1/de not_active IP Right Cessation
- 2002-04-29 EE EEP200300587A patent/EE200300587A/xx unknown
- 2002-04-29 CZ CZ20033066A patent/CZ299755B6/cs not_active IP Right Cessation
- 2002-04-29 GE GE5340A patent/GEP20053620B/en unknown
- 2002-04-29 JP JP2002590939A patent/JP2004534764A/ja active Pending
- 2002-04-29 WO PCT/IB2002/001500 patent/WO2002094220A1/en not_active Ceased
- 2002-04-29 IL IL15835902A patent/IL158359A0/xx unknown
- 2002-04-29 CA CA002446574A patent/CA2446574C/en not_active Expired - Fee Related
- 2002-05-21 MY MYPI20021869A patent/MY128615A/en unknown
- 2002-05-22 EG EG20020541A patent/EG24078A/xx active
- 2002-05-23 PE PE2002000433A patent/PE20030087A1/es not_active Application Discontinuation
- 2002-05-23 AR ARP020101922A patent/AR033922A1/es unknown
- 2002-05-23 DO DO2002000403A patent/DOP2002000403A/es unknown
- 2002-05-24 SV SV2002001053A patent/SV2003001053A/es not_active Application Discontinuation
- 2002-05-24 PA PA20028545901A patent/PA8545901A1/es unknown
- 2002-05-28 US US10/156,213 patent/US20020198261A1/en not_active Abandoned
2003
- 2003-06-24 US US10/602,215 patent/US7256216B2/en not_active Expired - Lifetime
- 2003-10-09 IS IS6986A patent/IS2428B/is unknown
- 2003-10-28 ZA ZA2003/08393A patent/ZA200308393B/en unknown
- 2003-11-17 CR CR7150A patent/CR7150A/es not_active Application Discontinuation
- 2003-11-19 MA MA27406A patent/MA27026A1/fr unknown
- 2003-11-21 BG BG108376A patent/BG108376A/bg unknown
- 2003-11-24 NO NO20035200A patent/NO20035200L/no not_active Application Discontinuation
2006
- 2006-08-10 CY CY20061101125T patent/CY1105147T1/el unknown

Also Published As

Publication number	Publication date
CA2446574A1 (en)	2002-11-28
MA27026A1 (fr)	2004-12-20
NO20035200D0 (no)	2003-11-24
GEP20053620B (en)	2005-09-26
CA2446574C (en)	2008-04-01
KR100582963B1 (ko)	2006-05-24
US20040072904A1 (en)	2004-04-15
BG108376A (bg)	2005-04-30
KR20040003006A (ko)	2004-01-07
CZ299755B6 (cs)	2008-11-12
IL158359A0 (en)	2004-05-12
EP1395242A1 (de)	2004-03-10
US7256216B2 (en)	2007-08-14
US20020198261A1 (en)	2002-12-26
NZ529173A (en)	2005-07-29
RS87203A (sr)	2006-10-27
CY1105147T1 (el)	2010-03-03
CZ20033066A3 (cs)	2004-08-18
SV2003001053A (es)	2003-03-18
HRP20030833B1 (en)	2007-04-30
DOP2002000403A (es)	2002-11-30
EP1395242B1 (de)	2006-08-02
PL366384A1 (en)	2005-01-24
PA8545901A1 (es)	2003-09-05
OA12604A (en)	2006-06-08
CN1509165A (zh)	2004-06-30
AP1815A (en)	2008-01-04
HUP0401366A2 (hu)	2004-11-29
MY128615A (en)	2007-02-28
IS2428B (is)	2008-10-15
MXPA03009392A (es)	2004-01-29
PT1395242E (pt)	2006-11-30
PE20030087A1 (es)	2003-02-14
EE200300587A (et)	2004-02-16
AU2002258026B2 (en)	2007-08-02
EA008087B1 (ru)	2007-02-27
BR0209973A (pt)	2004-04-06
ZA200308393B (en)	2005-04-26
HRP20030833A2 (en)	2004-08-31
NO20035200L (no)	2003-11-24
SI1395242T1 (en)	2006-10-31
DE60213592D1 (de)	2006-09-14
DK1395242T3 (da)	2006-10-30
ES2265040T3 (es)	2007-02-01
CN100346779C (zh)	2007-11-07
WO2002094220A1 (en)	2002-11-28
DE60213592T2 (de)	2007-08-09
HK1062646A1 (zh)	2004-11-19
EG24078A (en)	2008-05-11
SK14112003A3 (sk)	2004-08-03
CR7150A (es)	2004-02-23
IS6986A (is)	2003-10-09
SK286227B6 (sk)	2008-05-06
JP2004534764A (ja)	2004-11-18
AR033922A1 (es)	2004-01-07
AP2003002907A0 (en)	2003-12-31
EA200301152A1 (ru)	2004-04-29

Legal Events

Date

Code

Title

Description

2007-05-15

UEP

Publication of translation of european patent specification

Ref document number: 1395242

Country of ref document: EP

2010-01-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE334656T1 (de)	2006-08-15	Flüssige pharmazeutische zusammensetzung
ATE307571T1 (de)	2005-11-15	Pharmazeutische formulierung enthaltend bicalutamid
DE60142197D1 (de)	2010-07-01	Pharmazeutische Zusammensetzung
FI20011478A0 (fi)	2001-07-05	Farmaseuttinen koostumus
NO20033384L (no)	2003-09-25	Farmasoytisk formulering
PL367180A1 (pl)	2005-02-21	Trwała kompozycja farmaceutyczna
ATE320244T1 (de)	2006-04-15	Pharmazeutische zusammensetzungen mit amlodipinmaleat
DE602004016967D1 (de)	2008-11-20	Flüssige pharmazeutische palonosetronformulierungen
ATE320807T1 (de)	2006-04-15	Pharmazeutische zusammensetzungen enthaltend tegaserod
NO20035627D0 (no)	2003-12-15	Farmasöytisk formulering
FI20022128A7 (fi)	2003-06-06	Farmaseuttinen koostumus
DE60211183D1 (de)	2006-06-08	Pharmazeutische zusammensetzung enthaltend lumiracoxib
ATE350016T1 (de)	2007-01-15	Bicalutamid enthaltende pharmazeutische zusammensetzung
ATE366128T1 (de)	2007-07-15	Pharmazeutische zusammensetzung
DE10291905D2 (de)	2004-05-27	Pharmazeutische Zusammensetzung
ATE350029T1 (de)	2007-01-15	Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
DE10107261B4 (de)	2005-03-10	Pharmazeutische Zusammensetzung
EP1413314A4 (de)	2004-12-22	Medizinische zusammensetzungen
NO20041236L (no)	2004-03-24	Farmasoytisk formulering
FI5468U1 (fi)	2002-07-30	Farmaseuttinen koostumus
SE0101326D0 (sv)	2001-04-12	Pharmaceutical formulation
SE0103565D0 (sv)	2001-10-25	Pharmaceutical formulation
SE0102957D0 (sv)	2001-09-04	Pharmaceutical formulation
SE0102572D0 (sv)	2001-07-19	Pharmaceutical formulation
SE0101325D0 (sv)	2001-04-12	Pharmaceutical formulation